activity_id,mol_chembl_id,compound_name,assay_chembl_id,assay_type,assay_cell_type,assay_organism,pref_name,description,standard_type,standard_relation,standard_value,standard_units,canonical_smiles,doc_chembl_id,title,journal,year,volume,issue,first_page,last_page,doi,pubmed_id,patent_id
346510,CHEMBL2096747,"5-Difluoromethoxy-2-(3,4-dimethoxy-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole",CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,145000.0,nM,COc1ccnc(C[S@@+]([O-])c2nc3ccc(OC(F)F)cc3[nH]2)c1OC,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
347799,CHEMBL101,"4-Butyl-1,2-diphenyl-pyrazolidine-3,5-dione",CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,19000.0,nM,CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
351878,CHEMBL171602,4-Hydroxy-3-((S)-3-oxo-1-phenyl-butyl)-chroman-2-one,CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,13600.0,nM,CC(=O)C[C@H](c1ccccc1)C1C(=O)Oc2ccccc2C1O,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
351879,CHEMBL354260,"(2S,4S)-2-Methoxy-2-methyl-4-phenyl-3,4,4a,10b-tetrahydro-2H-pyrano[3,2-c]chromen-5-one",CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,16000.0,nM,CO[C@]1(C)C[C@H](c2ccccc2)C2C(=O)Oc3ccccc3C2O1,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
353299,CHEMBL603,{3-[2-Methoxy-4-(toluene-2-sulfonylaminocarbonyl)-benzyl]-1-methyl-1H-indol-5-yl}-carbamic acid cyclopentyl ester,CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,2500.0,nM,COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
354884,CHEMBL50,"2-(3,4-Dihydroxy-phenyl)-3,5,7-trihydroxy-chromen-4-one",CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,27000.0,nM,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
354885,CHEMBL2110339,"2-(3,4-Dimethoxy-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole-5-carboxylic acid methyl ester",CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,64000.0,nM,COC(=O)c1ccc2[nH]c([S@@+]([O-])Cc3nccc(OC)c3OC)nc2c1,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
356342,CHEMBL1503,"5-Methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole",CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,45000.0,nM,COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
356343,CHEMBL2110247,"2-(3,4-Dimethoxy-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole-5-carboxylic acid methyl ester",CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,140000.0,nM,COC(=O)c1ccc2[nH]c([S@+]([O-])Cc3nccc(OC)c3OC)nc2c1,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
357729,CHEMBL2114277,"(9R)(11R) 2-Methoxy-2-methyl-4-phenyl-3,4-dihydro-2H-pyrano[3,2-c]chromen-5-one",CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,16000.0,nM,CO[C@@]1(C)C[C@H](c2ccccc2)c2c(c3ccccc3oc2=O)O1,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
360478,CHEMBL1627299,2-({[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole,CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,37000.0,nM,COCCCOc1ccnc(C[S@+]([O-])c2nc3ccccc3[nH]2)c1C,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
363167,CHEMBL103,"6b-Acetyl-8-(4-azido-3-iodo-phenyl)-4a,6a,8-trimethyl-3,4,4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-tetradecahydro-7,9-dioxa-pentaleno[2,1-a]phenanthren-2-one",CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,5500.0,nM,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
366209,CHEMBL163958,"spiro[9H-fluorene-9,4'-(tetrahydro-1'H-imidazole)]-2',5'-dione",CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,125000.0,nM,O=C1NC(=O)C2(N1)c1ccccc1-c1ccccc12,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
366210,CHEMBL150,"3,5,7-Trihydroxy-2-(4-hydroxy-phenyl)-chromen-4-one",CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,6000.0,nM,O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
367656,CHEMBL1466,Bishydroxycoumarin4-hydroxy-3-(4-hydroxy-2-oxo-2H-3-chromenylmethyl)-2H-2-chromenone,CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,1900.0,nM,O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
371809,CHEMBL16,"5,5-Diphenyl-imidazolidine-2,4-dione",CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,6000.0,nM,O=C1N=C(O)NC1(c1ccccc1)c1ccccc1,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
373286,CHEMBL170132,"(E)-(2S,5S)-7-[3-(4-Fluoro-phenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-hept-6-enoic acid",CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,3300.0,nM,CC(C)n1c(/C=C/[C@@H](O)C[C@H](O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
373287,CHEMBL1464,4-Hydroxy-3-(3-oxo-1-phenyl-butyl)-chromen-2-one,CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,20000.0,nM,CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
373288,CHEMBL353413,"2-(2,5-Dichloro-thiophene-3-sulfonylamino)-N-(1,3,5-trimethyl-1H-pyrazol-4-yl)-benzamide",CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,17000.0,nM,Cc1nn(C)c(C)c1NC(=O)c1ccccc1NS(=O)(=O)c1cc(Cl)sc1Cl,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
374707,CHEMBL1294,(6-Methoxy-quinolin-4-yl)-(5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol,CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,32000.0,nM,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
374708,CHEMBL1615209,2-[4-(3-Methoxy-propoxy)-3-methyl-pyridin-2-ylmethanesulfinyl]-1H-benzoimidazole,CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,36000.0,nM,COCCCOc1ccnc(C[S@@+]([O-])c2nc3ccccc3[nH]2)c1C,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
374709,CHEMBL368348,"1-[(R)-2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole",CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,6000.0,nM,Clc1ccc(CO[C@@H](Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
374710,CHEMBL171828,"2-Amino-6-chloro-3-(2,4-dichloro-phenoxy)-benzenesulfonic acid",CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,20000.0,nM,Nc1c(Oc2ccc(Cl)cc2Cl)ccc(Cl)c1S(=O)(=O)O,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
376085,CHEMBL173038,"1-[(S)-2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole",CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,6000.0,nM,Clc1ccc(CO[C@H](Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
377367,CHEMBL1109,4-Amino-N-(2-phenyl-2H-pyrazol-3-yl)-benzenesulfonamide,CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,500.0,nM,Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
377429,CHEMBL2110340,2-(4-Cyclopropylmethoxy-pyridin-2-ylmethanesulfinyl)-5-fluoro-1H-benzoimidazole,CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,93000.0,nM,[O-][S@+](Cc1cc(OCC2CC2)ccn1)c1nc2cc(F)ccc2[nH]1,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
380267,CHEMBL1344,"5-Methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfonyl)-1H-benzoimidazole",CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,35000.0,nM,COc1ccc2[nH]c(S(=O)(=O)Cc3ncc(C)c(OC)c3C)nc2c1,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
380268,CHEMBL625,2-Thiazol-4-yl-1H-benzoimidazole (Thiabendazole),CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,245000.0,nM,c1ccc2[nH]c(-c3cscn3)nc2c1,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
380269,CHEMBL2110248,2-(4-Cyclopropylmethoxy-pyridin-2-ylmethanesulfinyl)-5-fluoro-1H-benzoimidazole,CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,60000.0,nM,[O-][S@@+](Cc1cc(OCC2CC2)ccn1)c1nc2cc(F)ccc2[nH]1,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
383242,CHEMBL3526697,"5-Difluoromethoxy-2-(3,4-dimethoxy-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole",CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,64000.0,nM,COc1ccnc(C[S@+]([O-])c2nc3ccc(OC(F)F)cc3[nH]2)c1OC,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
384514,CHEMBL814,5-Methoxy-1-(4-trifluoromethyl-phenyl)-pentan-1-one O-(2-amino-ethyl)-oxime (Fluvoxamine),CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,8500.0,nM,COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
387593,CHEMBL36,"5-(4-Chloro-phenyl)-6-ethyl-pyrimidine-2,4-diamine",CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,51500.0,nM,CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
389069,CHEMBL1484,"2,6-Dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-[2-(benzyl-methyl-amino)-ethyl] ester 5-methyl ester",CHEMBL661230,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human cytochrome P450 2C9,Ki,=,280.0,nM,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
389118,CHEMBL170417,"(E)-(2R,5R)-7-[3-(4-Fluoro-phenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-hept-6-enoic acid",CHEMBL661229,A,,,Cytochrome P450 2C9,Binding affinity towards cytochrome P450 2C9,Ki,=,2200.0,nM,CC(C)n1c(/C=C/[C@H](O)C[C@@H](O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21,CHEMBL1148414,Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.,J. Med. Chem.,2004,47,4,907,914,10.1021/jm030972s,14761192,
1104915,CHEMBL2115268,(9S)(11S) 4-Hydroxy-3-(3-hydroxy-1-phenyl-butyl)-chromen-2-one,CHEMBL661223,A,,,Cytochrome P450 2C9,Binding affinity was measured on Cytochrome P450 2C9,Ki,=,3000.0,nM,C[C@H](O)C[C@@H](c1ccccc1)c1c(O)oc2ccccc2c1=O,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1104916,CHEMBL2114286,(9R)(11S) 4-Hydroxy-3-(3-hydroxy-1-phenyl-butyl)-chromen-2-one,CHEMBL661223,A,,,Cytochrome P450 2C9,Binding affinity was measured on Cytochrome P450 2C9,Ki,=,400.0,nM,C[C@H](O)C[C@H](c1ccccc1)c1c(O)oc2ccccc2c1=O,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1104977,CHEMBL521,2-(4-Isobutyl-phenyl)-propionic acid,CHEMBL840930,A,,,Cytochrome P450 2C9,Binding affinity measured on human cytochrome P450 2C9 (CYP2C9) enzyme,Ki,=,50000.0,nM,CC(C)Cc1ccc(C(C)C(=O)O)cc1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1107422,CHEMBL2115267,(9S)4-Methoxy-3-(1-phenyl-propyl)-chromen-2-one,CHEMBL661223,A,,,Cytochrome P450 2C9,Binding affinity was measured on Cytochrome P450 2C9,Ki,=,6000.0,nM,CC[C@@H](c1ccccc1)c1c(OC)c2ccccc2oc1=O,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1107467,CHEMBL1109,4-Amino-N-(2-phenyl-2H-pyrazol-3-yl)-benzenesulfonamide,CHEMBL840930,A,,,Cytochrome P450 2C9,Binding affinity measured on human cytochrome P450 2C9 (CYP2C9) enzyme,Ki,=,200.0,nM,Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1108484,CHEMBL2114281,(9R)2-Methoxy-3-(1-phenyl-propyl)-chromen-4-one,CHEMBL661223,A,,,Cytochrome P450 2C9,Binding affinity was measured on Cytochrome P450 2C9,Ki,=,14000.0,nM,CC[C@H](c1ccccc1)c1c(OC)oc2ccccc2c1=O,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1108547,CHEMBL317083,1N-benzyl-2-[4-(1-ethynyl)phenylsulfonyl]urea,CHEMBL840930,A,,,Cytochrome P450 2C9,Binding affinity measured on human cytochrome P450 2C9 (CYP2C9) enzyme,Ki,=,25000.0,nM,C#Cc1ccc(S(=O)(=O)NC(=O)NCc2ccccc2)cc1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1108548,CHEMBL94536,4-Ethynyl-N-(5-methyl-isoxazol-3-yl)-benzenesulfonamide,CHEMBL840930,A,,,Cytochrome P450 2C9,Binding affinity measured on human cytochrome P450 2C9 (CYP2C9) enzyme,Ki,=,3000.0,nM,C#Cc1ccc(S(=O)(=O)Nc2cc(C)on2)cc1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1109546,CHEMBL352395,"(9R)(11S) 2-Methoxy-2-methyl-4-phenyl-3,4-dihydro-2H-pyrano[3,2-c]chromen-5-one",CHEMBL661223,A,,,Cytochrome P450 2C9,Binding affinity was measured on Cytochrome P450 2C9,Ki,=,7000.0,nM,CO[C@@]1(C)C[C@@H](c2ccccc2)c2c(c3ccccc3oc2=O)O1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1110837,CHEMBL94358,6-Ethynyl-4-hydroxy-3-(2-oxo-1-phenyl-propyl)-chromen-2-one,CHEMBL661223,A,,,Cytochrome P450 2C9,Binding affinity was measured on Cytochrome P450 2C9,Ki,=,1500.0,nM,C#Cc1ccc2oc(O)c(C(C(C)=O)c3ccccc3)c(=O)c2c1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1110838,CHEMBL94767,4-Azido-N-(2-phenyl-2H-pyrazol-3-yl)-benzenesulfonamide,CHEMBL661223,A,,,Cytochrome P450 2C9,Binding affinity was measured on Cytochrome P450 2C9,Ki,=,400.0,nM,[N-]=[N+]=Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1111920,CHEMBL2115262,"(9S)(11S) 2-Methoxy-2-methyl-4-phenyl-3,4-dihydro-2H-pyrano[3,2-c]chromen-5-one",CHEMBL661223,A,,,Cytochrome P450 2C9,Binding affinity was measured on Cytochrome P450 2C9,Ki,=,20000.0,nM,CO[C@]1(C)C[C@@H](c2ccccc2)c2c(c3ccccc3oc2=O)O1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1113184,CHEMBL96608,"3-(2,5-Dimethyl-phenoxy)-2,2-dimethyl-propionic acid",CHEMBL840930,A,,,Cytochrome P450 2C9,Binding affinity measured on human cytochrome P450 2C9 (CYP2C9) enzyme,Ki,=,15000.0,nM,Cc1ccc(C)c(OCC(C)(C)C(=O)O)c1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1114460,CHEMBL2114283,(9R)(11R)4-Hydroxy-3-(3-hydroxy-1-phenyl-butyl)-chromen-2-one,CHEMBL661223,A,,,Cytochrome P450 2C9,Binding affinity was measured on Cytochrome P450 2C9,Ki,=,3000.0,nM,C[C@@H](O)C[C@H](c1ccccc1)c1c(O)oc2ccccc2c1=O,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1115679,CHEMBL2115260,(9S)2-Methoxy-3-(3-oxo-1-phenyl-butyl)-chromen-4-one,CHEMBL840930,A,,,Cytochrome P450 2C9,Binding affinity measured on human cytochrome P450 2C9 (CYP2C9) enzyme,Ki,=,21000.0,nM,COc1oc2ccccc2c(=O)c1[C@@H](CC(C)=O)c1ccccc1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1116832,CHEMBL96214,N-(2-Phenyl-2H-pyrazol-3-yl)-benzenesulfonamide,CHEMBL840930,A,,,Cytochrome P450 2C9,Binding affinity measured on human cytochrome P450 2C9 (CYP2C9) enzyme,Ki,=,2000.0,nM,O=S(=O)(Nc1ccnn1-c1ccccc1)c1ccccc1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1119262,CHEMBL16,"5,5-Diphenyl-imidazolidine-2,4-dione",CHEMBL661223,A,,,Cytochrome P450 2C9,Binding affinity was measured on Cytochrome P450 2C9,Ki,=,10000.0,nM,O=C1N=C(O)NC1(c1ccccc1)c1ccccc1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1120356,CHEMBL1466,Bishydroxycoumarin4-hydroxy-3-(4-hydroxy-2-oxo-2H-3-chromenylmethyl)-2H-2-chromenone,CHEMBL661223,A,,,Cytochrome P450 2C9,Binding affinity was measured on Cytochrome P450 2C9,Ki,=,600.0,nM,O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1120357,CHEMBL2114284,(9S)4-Methoxy-3-(3-oxo-1-phenyl-butyl)-chromen-2-one,CHEMBL661223,A,,,Cytochrome P450 2C9,Binding affinity was measured on Cytochrome P450 2C9,Ki,=,10000.0,nM,COc1c([C@H](CC(C)=O)c2ccccc2)c(=O)oc2ccccc12,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1121529,CHEMBL2115263,"(9S) 2-Hydroxy-2-methyl-4-phenyl-3,4-dihydro-2H-pyrano[3,2-c]chromen-5-one",CHEMBL661223,A,,,Cytochrome P450 2C9,Binding affinity was measured on Cytochrome P450 2C9,Ki,=,25000.0,nM,CC1(O)C[C@@H](c2ccccc2)c2c(c3ccccc3oc2=O)O1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1121530,CHEMBL2115265,(9S) 2-Methoxy-3-(1-phenyl-propyl)-chromen-4-one,CHEMBL661223,A,,,Cytochrome P450 2C9,Binding affinity was measured on Cytochrome P450 2C9,Ki,=,100.0,nM,CC[C@@H](c1ccccc1)c1c(OC)oc2ccccc2c1=O,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1121568,CHEMBL2114275,(9R) 2-Methoxy-3-(3-oxo-1-phenyl-butyl)-chromen-4-one,CHEMBL661224,A,,Homo sapiens,Cytochrome P450 2C9,Binding affinity for human Cytochrome P450 2C9,Ki,=,29000.0,nM,COc1oc2ccccc2c(=O)c1[C@H](CC(C)=O)c1ccccc1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1121569,CHEMBL782,N-[(butylamino)carbonyl]-4-methylbenzenesulfonamide,CHEMBL840930,A,,,Cytochrome P450 2C9,Binding affinity measured on human cytochrome P450 2C9 (CYP2C9) enzyme,Ki,=,70000.0,nM,CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1122718,CHEMBL2079628,(9S) 4-Hydroxy-3-(1-phenyl-propyl)-chromen-2-one,CHEMBL661223,A,,,Cytochrome P450 2C9,Binding affinity was measured on Cytochrome P450 2C9,Ki,=,500.0,nM,CC[C@H](c1ccccc1)c1c(O)oc2ccccc2c1=O,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1125090,CHEMBL96685,6-azido-3-(6-azido-4-hydroxy-2-oxo-2H-3-chromenylmethyl)-4-hydroxy-2H-2-chromenone,CHEMBL661223,A,,,Cytochrome P450 2C9,Binding affinity was measured on Cytochrome P450 2C9,Ki,=,3000.0,nM,[N-]=[N+]=Nc1ccc2oc(O)c(Cc3c(O)oc4ccc(N=[N+]=[N-])cc4c3=O)c(=O)c2c1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1125091,CHEMBL2114277,"(9R)(11R) 2-Methoxy-2-methyl-4-phenyl-3,4-dihydro-2H-pyrano[3,2-c]chromen-5-one",CHEMBL661223,A,,,Cytochrome P450 2C9,Binding affinity was measured on Cytochrome P450 2C9,Ki,=,1500.0,nM,CO[C@@]1(C)C[C@H](c2ccccc2)c2c(c3ccccc3oc2=O)O1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1125148,CHEMBL321723,1N-isobutyl-2-[4-(1-ethynyl)phenylsulfonyl]urea,CHEMBL840930,A,,,Cytochrome P450 2C9,Binding affinity measured on human cytochrome P450 2C9 (CYP2C9) enzyme,Ki,=,48000.0,nM,C#Cc1ccc(S(=O)(=O)NC(=O)NCC(C)C)cc1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1125149,CHEMBL432386,4-Methyl-N-(2-phenyl-2H-pyrazol-3-yl)-benzenesulfonamide,CHEMBL840930,A,,,Cytochrome P450 2C9,Binding affinity measured on human cytochrome P450 2C9 (CYP2C9) enzyme,Ki,=,100.0,nM,Cc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1126436,CHEMBL2115266,(9S)(11R) 4-Hydroxy-3-(3-hydroxy-1-phenyl-butyl)-chromen-2-one,CHEMBL661223,A,,,Cytochrome P450 2C9,Binding affinity was measured on Cytochrome P450 2C9,Ki,=,100.0,nM,C[C@@H](O)C[C@@H](c1ccccc1)c1c(O)oc2ccccc2c1=O,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1126483,CHEMBL94585,"5-(4-Ethynyl-phenyl)-5-phenyl-imidazolidine-2,4-dione",CHEMBL840930,A,,,Cytochrome P450 2C9,Binding affinity measured on human cytochrome P450 2C9 (CYP2C9) enzyme,Ki,=,18000.0,nM,C#Cc1ccc(C2(c3ccccc3)NC(=O)NC2=O)cc1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1127663,CHEMBL318439,1N-phenyl-2-[4-(1-ethynyl)phenylsulfonyl]urea,CHEMBL840930,A,,,Cytochrome P450 2C9,Binding affinity measured on human cytochrome P450 2C9 (CYP2C9) enzyme,Ki,=,7000.0,nM,C#Cc1ccc(S(=O)(=O)NC(=O)Nc2ccccc2)cc1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1128937,CHEMBL2079628,(9S) 4-Hydroxy-3-(1-phenyl-propyl)-chromen-2-one,CHEMBL661223,A,,,Cytochrome P450 2C9,Binding affinity was measured on Cytochrome P450 2C9,Ki,=,18000.0,nM,CC[C@H](c1ccccc1)c1c(O)oc2ccccc2c1=O,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1129956,CHEMBL2114285,(9R) 4-Methoxy-3-(1-phenyl-propyl)-chromen-2-one,CHEMBL661223,A,,,Cytochrome P450 2C9,Binding affinity was measured on Cytochrome P450 2C9,Ki,=,13000.0,nM,CC[C@H](c1ccccc1)c1c(OC)c2ccccc2oc1=O,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1131128,CHEMBL2114284,(9S)4-Methoxy-3-(3-oxo-1-phenyl-butyl)-chromen-2-one,CHEMBL661223,A,,,Cytochrome P450 2C9,Binding affinity was measured on Cytochrome P450 2C9,Ki,=,2400.0,nM,COc1c([C@H](CC(C)=O)c2ccccc2)c(=O)oc2ccccc12,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1132280,CHEMBL93714,4-Acetyl-N-(2-phenyl-2H-pyrazol-3-yl)-benzenesulfonamide,CHEMBL840930,A,,,Cytochrome P450 2C9,Binding affinity measured on human cytochrome P450 2C9 (CYP2C9) enzyme,Ki,=,2400.0,nM,CC(=O)c1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1133449,CHEMBL320460,7-Ethynyl-4-hydroxy-3-(2-oxo-1-phenyl-propyl)-chromen-2-one,CHEMBL661223,A,,,Cytochrome P450 2C9,Binding affinity was measured on Cytochrome P450 2C9,Ki,=,1100.0,nM,C#Cc1ccc2c(=O)c(C(C(C)=O)c3ccccc3)c(O)oc2c1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1133517,CHEMBL267744,"[2,3-Dichloro-4-(thiophene-2-carbonyl)-phenoxy]-acetic acid (ticrynafen)",CHEMBL840930,A,,,Cytochrome P450 2C9,Binding affinity measured on human cytochrome P450 2C9 (CYP2C9) enzyme,Ki,=,11000.0,nM,O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1135065,CHEMBL77981,"[2-(2,5-Dichloro-phenylamino)-phenyl]-acetic acid",CHEMBL840930,A,,,Cytochrome P450 2C9,Binding affinity measured on human cytochrome P450 2C9 (CYP2C9) enzyme,Ki,=,2000.0,nM,O=C(O)Cc1ccccc1Nc1cc(Cl)ccc1Cl,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1137470,CHEMBL2114278,"(9R) 2-Hydroxy-2-methyl-4-phenyl-3,4-dihydro-2H-pyrano[3,2-c]chromen-5-one",CHEMBL661223,A,,,Cytochrome P450 2C9,Binding affinity was measured on Cytochrome P450 2C9,Ki,=,7000.0,nM,CC1(O)C[C@H](c2ccccc2)c2c(c3ccccc3oc2=O)O1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1137471,CHEMBL352395,"(9R)(11S) 2-Methoxy-2-methyl-4-phenyl-3,4-dihydro-2H-pyrano[3,2-c]chromen-5-one",CHEMBL661223,A,,,Cytochrome P450 2C9,Binding affinity was measured on Cytochrome P450 2C9,Ki,=,1100.0,nM,CO[C@@]1(C)C[C@@H](c2ccccc2)c2c(c3ccccc3oc2=O)O1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1137527,CHEMBL956,2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid,CHEMBL840930,A,,,Cytochrome P450 2C9,Binding affinity measured on human cytochrome P450 2C9 (CYP2C9) enzyme,Ki,=,45000.0,nM,CC(C(=O)O)c1ccc(C(=O)c2cccs2)cc1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1140162,CHEMBL94334,1N-butyl-2-[4-(1-ethynyl)phenylsulfonyl]urea,CHEMBL840930,A,,,Cytochrome P450 2C9,Binding affinity measured on human cytochrome P450 2C9 (CYP2C9) enzyme,Ki,=,18000.0,nM,C#Cc1ccc(S(=O)(=O)NC(=O)NCCCC)cc1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1140163,CHEMBL316653,4-Hydroxy-N-(2-phenyl-2H-pyrazol-3-yl)-benzenesulfonamide,CHEMBL840930,A,,,Cytochrome P450 2C9,Binding affinity measured on human cytochrome P450 2C9 (CYP2C9) enzyme,Ki,=,6000.0,nM,O=S(=O)(Nc1ccnn1-c1ccccc1)c1ccc(O)cc1,CHEMBL1133779,A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.,J. Med. Chem.,2000,43,15,2789,2796,10.1021/jm000048n,10956186,
1782136,CHEMBL359657,C-(5-Pyridin-3-yl-thiophen-2-yl)-methylamine,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,=,4500.0,nM,NCc1ccc(-c2cccnc2)s1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782222,CHEMBL217125,(3-(pyridin-3-yl)isoxazol-5-yl)methanamine,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,=,14500.0,nM,NCc1cc(-c2cccnc2)no1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782223,CHEMBL385008,(3-(pyridin-3-yl)-1H-pyrazol-5-yl)methanamine,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,=,24200.0,nM,NCc1cc(-c2cccnc2)n[nH]1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782224,CHEMBL385023,3-(pyridin-3-yl)propan-1-amine,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,>,400000.0,nM,NCCCc1cccnc1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782225,CHEMBL218397,3-(1H-pyrazol-3-yl)pyridine,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,=,172000.0,nM,c1cncc(-c2cc[nH]n2)c1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782226,CHEMBL410355,3-(4-methylthiazol-2-yl)pyridine,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,=,51500.0,nM,Cc1csc(-c2cccnc2)n1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782227,CHEMBL386250,3-phenylthiophene,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,=,112000.0,nM,c1ccc(-c2ccsc2)cc1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782228,CHEMBL215183,3-methyl-4-phenylthiophene,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,>,400000.0,nM,Cc1cscc1-c1ccccc1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782229,CHEMBL215134,(5-phenylthiophen-2-yl)methanamine,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,=,500.0,nM,NCc1ccc(-c2ccccc2)s1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782230,CHEMBL214859,(5-phenylfuran-2-yl)methanamine,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,=,900.0,nM,NCc1ccc(-c2ccccc2)o1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782231,CHEMBL215174,"3-(5-[1,3]dithiolan-2-yl-furan-2-yl)pyridine",CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,=,1300.0,nM,c1cncc(-c2ccc(C3SCCS3)o2)c1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782232,CHEMBL214990,3-(5-((methylthio)methyl)furan-2-yl)pyridine,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,=,14100.0,nM,CSCc1ccc(-c2cccnc2)o1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782233,CHEMBL214784,(5-pyridin-3-yl-furan-2-yl)methanethiol,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,=,400.0,nM,SCc1ccc(-c2cccnc2)o1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782234,CHEMBL386124,S-(5-(Pyridin-3-yl)furan-2-yl)methyl ethanethioate,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,=,2900.0,nM,CC(=O)SCc1ccc(-c2cccnc2)o1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782235,CHEMBL179704,3-(4-Methyl-thiophen-3-yl)-pyridine,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,=,61500.0,nM,Cc1cscc1-c1cccnc1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782236,CHEMBL178516,3-(1H-Imidazol-4-yl)-pyridine,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,=,20900.0,nM,c1cncc(-c2c[nH]cn2)c1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782237,CHEMBL368883,3-(2-Methyl-imidazol-1-yl)-pyridine,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,>,300000.0,nM,Cc1nccn1-c1cccnc1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782238,CHEMBL361153,3-Thiophen-3-yl-pyridine,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,=,48200.0,nM,c1cncc(-c2ccsc2)c1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782239,CHEMBL179621,2-Fluoro-5-(3-methyl-thiophen-2-yl)-pyridine,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,>,400000.0,nM,Cc1ccsc1-c1ccc(F)nc1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782240,CHEMBL360999,3-(1-Methyl-1H-imidazol-4-yl)-pyridine,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,=,39700.0,nM,Cn1cnc(-c2cccnc2)c1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782241,CHEMBL179669,3-(3-Methyl-thiophen-2-yl)-pyridine,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,=,46600.0,nM,Cc1ccsc1-c1cccnc1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782242,CHEMBL149808,Methyl-(3-pyridin-3-yl-prop-2-ynyl)-amine,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,=,6300.0,nM,CNCC#Cc1cccnc1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782243,CHEMBL360541,3-Pyridin-3-yl-prop-2-ynylamine,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,=,1200.0,nM,NCC#Cc1cccnc1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782244,CHEMBL360998,Dimethyl-(5-pyridin-3-yl-furan-2-ylmethyl)-amine,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,=,111000.0,nM,CN(C)Cc1ccc(-c2cccnc2)o1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782245,CHEMBL178938,Methyl-(5-pyridin-3-yl-furan-2-ylmethyl)-amine,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,=,38100.0,nM,CNCc1ccc(-c2cccnc2)o1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782246,CHEMBL361969,Dimethyl-(5-pyridin-3-yl-thiophen-2-ylmethyl)-amine,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,=,103000.0,nM,CN(C)Cc1ccc(-c2cccnc2)s1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782247,CHEMBL369285,Methyl-(5-pyridin-3-yl-thiophen-2-ylmethyl)-amine,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,=,33900.0,nM,CNCc1ccc(-c2cccnc2)s1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782257,CHEMBL180270,Dimethyl-(3-pyridin-3-yl-prop-2-ynyl)-amine,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,>,400000.0,nM,CN(C)CC#Cc1cccnc1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1782258,CHEMBL178090,C-(5-Pyridin-3-yl-furan-2-yl)-methylamine,CHEMBL910039,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,=,5900.0,nM,NCc1ccc(-c2cccnc2)o1,CHEMBL1137358,"Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.",J. Med. Chem.,2006,49,24,6987,7001,10.1021/jm060519r,17125252,
1842737,CHEMBL225481,"(2-ethylbenzofuran-3-yl)(4-hydroxy-3,5-dimethylphenyl)methanone",CHEMBL916313,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,=,40.0,nM,CCc1oc2ccccc2c1C(=O)c1cc(C)c(O)c(C)c1,CHEMBL1149305,Charge and substituent effects on affinity and metabolism of benzbromarone-based CYP2C19 inhibitors.,J. Med. Chem.,2004,47,27,6768,6776,10.1021/jm049605m,15615526,
1842740,CHEMBL388590,benzbromarone,CHEMBL916313,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of human CYP2C9,Ki,=,19.0,nM,CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1,CHEMBL1149305,Charge and substituent effects on affinity and metabolism of benzbromarone-based CYP2C19 inhibitors.,J. Med. Chem.,2004,47,27,6768,6776,10.1021/jm049605m,15615526,
2069447,CHEMBL251070,N-((4-chlorobenzylamino)(cyclohexyl(isopropyl)amino)methylene)-N-methylmethanaminium,CHEMBL945056,A,,,Cytochrome P450 2C9,Inhibition of CYP2C9,Ki,=,50315292298.93,nM,CC(C)N(C(NCc1ccc(Cl)cc1)=[N+](C)C)C1CCCCC1,CHEMBL1140752,High confidence predictions of drug-drug interactions: predicting affinities for cytochrome P450 2C9 with multiple computational methods.,J. Med. Chem.,2008,51,3,648,654,10.1021/jm701130z,18211009,
2069448,CHEMBL611490,"1-[3-(2,4-dichloro-phenoxy)-2-hydroxy-propyl]-2-pyridin-2-yl-pyrrolidinium",CHEMBL945056,A,,,Cytochrome P450 2C9,Inhibition of CYP2C9,Ki,=,136804379305693.1,nM,OC(COc1ccc(Cl)cc1Cl)CN1CCCC1c1ccccn1,CHEMBL1140752,High confidence predictions of drug-drug interactions: predicting affinities for cytochrome P450 2C9 with multiple computational methods.,J. Med. Chem.,2008,51,3,648,654,10.1021/jm701130z,18211009,
2069449,CHEMBL250080,"N-(3-(2,4-difluorophenyl)-1-oxo-1-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)prop-2-en-2-yl)-4-methylbenzamide",CHEMBL945056,A,,,Cytochrome P450 2C9,Inhibition of CYP2C9,Ki,=,71121351365332.95,nM,Cc1ccc(C(=O)N/C(=C/c2ccc(F)cc2F)C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)cc1,CHEMBL1140752,High confidence predictions of drug-drug interactions: predicting affinities for cytochrome P450 2C9 with multiple computational methods.,J. Med. Chem.,2008,51,3,648,654,10.1021/jm701130z,18211009,
2069450,CHEMBL608833,cyclopropylmethyl-[4-(2-methyl-benzylsulfamoyl)-benzyl]-propyl-ammonium,CHEMBL945056,A,,,Cytochrome P450 2C9,Inhibition of CYP2C9,Ki,=,689604362163702.8,nM,CCCN(Cc1ccc(S(=O)(=O)NCc2ccccc2C)cc1)CC1CC1,CHEMBL1140752,High confidence predictions of drug-drug interactions: predicting affinities for cytochrome P450 2C9 with multiple computational methods.,J. Med. Chem.,2008,51,3,648,654,10.1021/jm701130z,18211009,
2069451,CHEMBL121626,2-(3-Chloro-2-methyl-phenylamino)-benzoic acid,CHEMBL945056,A,,,Cytochrome P450 2C9,Inhibition of CYP2C9,Ki,=,537650433122253.3,nM,Cc1c(Cl)cccc1Nc1ccccc1C(=O)O,CHEMBL1140752,High confidence predictions of drug-drug interactions: predicting affinities for cytochrome P450 2C9 with multiple computational methods.,J. Med. Chem.,2008,51,3,648,654,10.1021/jm701130z,18211009,
2069452,CHEMBL608832,1-[3-(2-benzooxazol-2-yl-phenoxy)-2-hydroxy-propyl]-2-pyridin-3-yl-pyrrolidinium,CHEMBL945056,A,,,Cytochrome P450 2C9,Inhibition of CYP2C9,Ki,=,185182524363817.8,nM,OC(COc1ccccc1-c1nc2ccccc2o1)CN1CCCC1c1cccnc1,CHEMBL1140752,High confidence predictions of drug-drug interactions: predicting affinities for cytochrome P450 2C9 with multiple computational methods.,J. Med. Chem.,2008,51,3,648,654,10.1021/jm701130z,18211009,
2069453,CHEMBL23588,2-(3-Trifluoromethyl-phenylamino)-benzoic acid,CHEMBL945056,A,,,Cytochrome P450 2C9,Inhibition of CYP2C9,Ki,=,115904420522271.9,nM,O=C(O)c1ccccc1Nc1cccc(C(F)(F)F)c1,CHEMBL1140752,High confidence predictions of drug-drug interactions: predicting affinities for cytochrome P450 2C9 with multiple computational methods.,J. Med. Chem.,2008,51,3,648,654,10.1021/jm701130z,18211009,
2069454,CHEMBL1162079,4-[oxido({[(propan-2-yl)carbamoyl]imino})sulfinyl]benzonitrile,CHEMBL945056,A,,,Cytochrome P450 2C9,Inhibition of CYP2C9,Ki,=,20835311605717.46,nM,CC(C)NC(=O)N=S(=O)(O)c1ccc(C#N)cc1,CHEMBL1140752,High confidence predictions of drug-drug interactions: predicting affinities for cytochrome P450 2C9 with multiple computational methods.,J. Med. Chem.,2008,51,3,648,654,10.1021/jm701130z,18211009,
2069455,CHEMBL388590,benzbromarone,CHEMBL945056,A,,,Cytochrome P450 2C9,Inhibition of CYP2C9,Ki,=,19.0,nM,CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1,CHEMBL1140752,High confidence predictions of drug-drug interactions: predicting affinities for cytochrome P450 2C9 with multiple computational methods.,J. Med. Chem.,2008,51,3,648,654,10.1021/jm701130z,18211009,
2069456,CHEMBL250251,"3-(3,5-dibromo-4-hydroxybenzoyl)-2-ethyl-4H-chromen-4-one",CHEMBL945056,A,,,Cytochrome P450 2C9,Inhibition of CYP2C9,Ki,=,101.0,nM,CCc1oc2ccccc2c(=O)c1C(=O)c1cc(Br)c(O)c(Br)c1,CHEMBL1140752,High confidence predictions of drug-drug interactions: predicting affinities for cytochrome P450 2C9 with multiple computational methods.,J. Med. Chem.,2008,51,3,648,654,10.1021/jm701130z,18211009,
2192900,CHEMBL388590,benzbromarone,CHEMBL972103,A,,,Cytochrome P450 2C9,Binding affinity to CYP2C9,Ki,=,19.0,nM,CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1,CHEMBL1157143,Modeling and synthesis of novel tight-binding inhibitors of cytochrome P450 2C9.,Bioorg. Med. Chem.,2008,16,7,4064,4074,10.1016/j.bmc.2008.01.021,18255300,
2192901,CHEMBL458567,"3-(4-hydroxy-3,5-diiodobenzoyl)-2-methyl-4H-chromen-4-one",CHEMBL972103,A,,,Cytochrome P450 2C9,Binding affinity to CYP2C9,Ki,=,41.0,nM,Cc1oc2ccccc2c(=O)c1C(=O)c1cc(I)c(O)c(I)c1,CHEMBL1157143,Modeling and synthesis of novel tight-binding inhibitors of cytochrome P450 2C9.,Bioorg. Med. Chem.,2008,16,7,4064,4074,10.1016/j.bmc.2008.01.021,18255300,
2192903,CHEMBL465715,3-(4-hydroxybenzoyl)-2-propyl-4H-chromen-4-one,CHEMBL972103,A,,,Cytochrome P450 2C9,Binding affinity to CYP2C9,Ki,=,656.0,nM,CCCc1oc2ccccc2c(=O)c1C(=O)c1ccc(O)cc1,CHEMBL1157143,Modeling and synthesis of novel tight-binding inhibitors of cytochrome P450 2C9.,Bioorg. Med. Chem.,2008,16,7,4064,4074,10.1016/j.bmc.2008.01.021,18255300,
2192904,CHEMBL465664,2-ethyl-3-(4-hydroxybenzoyl)-4H-chromen-4-one,CHEMBL972103,A,,,Cytochrome P450 2C9,Binding affinity to CYP2C9,Ki,=,1420.0,nM,CCc1oc2ccccc2c(=O)c1C(=O)c1ccc(O)cc1,CHEMBL1157143,Modeling and synthesis of novel tight-binding inhibitors of cytochrome P450 2C9.,Bioorg. Med. Chem.,2008,16,7,4064,4074,10.1016/j.bmc.2008.01.021,18255300,
2192906,CHEMBL445600,3-(4-hydroxybenzoyl)-2-methyl-4H-chromen-4-one,CHEMBL972103,A,,,Cytochrome P450 2C9,Binding affinity to CYP2C9,Ki,=,6740.0,nM,Cc1oc2ccccc2c(=O)c1C(=O)c1ccc(O)cc1,CHEMBL1157143,Modeling and synthesis of novel tight-binding inhibitors of cytochrome P450 2C9.,Bioorg. Med. Chem.,2008,16,7,4064,4074,10.1016/j.bmc.2008.01.021,18255300,
2192908,CHEMBL250251,"3-(3,5-dibromo-4-hydroxybenzoyl)-2-ethyl-4H-chromen-4-one",CHEMBL972103,A,,,Cytochrome P450 2C9,Binding affinity to CYP2C9,Ki,=,101.0,nM,CCc1oc2ccccc2c(=O)c1C(=O)c1cc(Br)c(O)c(Br)c1,CHEMBL1157143,Modeling and synthesis of novel tight-binding inhibitors of cytochrome P450 2C9.,Bioorg. Med. Chem.,2008,16,7,4064,4074,10.1016/j.bmc.2008.01.021,18255300,
2192910,CHEMBL456432,"3-(4-hydroxy-3,5-diiodobenzoyl)-2-propyl-4H-chromen-4-one",CHEMBL972103,A,,,Cytochrome P450 2C9,Binding affinity to CYP2C9,Ki,=,4.2,nM,CCCc1oc2ccccc2c(=O)c1C(=O)c1cc(I)c(O)c(I)c1,CHEMBL1157143,Modeling and synthesis of novel tight-binding inhibitors of cytochrome P450 2C9.,Bioorg. Med. Chem.,2008,16,7,4064,4074,10.1016/j.bmc.2008.01.021,18255300,
2192912,CHEMBL458566,"2-ethyl-3-(4-hydroxy-3,5-diiodobenzoyl)-4H-chromen-4-one",CHEMBL972103,A,,,Cytochrome P450 2C9,Binding affinity to CYP2C9,Ki,=,23.0,nM,CCc1oc2ccccc2c(=O)c1C(=O)c1cc(I)c(O)c(I)c1,CHEMBL1157143,Modeling and synthesis of novel tight-binding inhibitors of cytochrome P450 2C9.,Bioorg. Med. Chem.,2008,16,7,4064,4074,10.1016/j.bmc.2008.01.021,18255300,
2192914,CHEMBL465716,3-(4-methoxybenzoyl)-2-methyl-4H-chromen-4-one,CHEMBL972103,A,,,Cytochrome P450 2C9,Binding affinity to CYP2C9,Ki,=,5930.0,nM,COc1ccc(C(=O)c2c(C)oc3ccccc3c2=O)cc1,CHEMBL1157143,Modeling and synthesis of novel tight-binding inhibitors of cytochrome P450 2C9.,Bioorg. Med. Chem.,2008,16,7,4064,4074,10.1016/j.bmc.2008.01.021,18255300,
2192915,CHEMBL457087,"3-(3,5-diiodo-4-methoxybenzoyl)-2-propyl-4H-chromen-4-one",CHEMBL972103,A,,,Cytochrome P450 2C9,Binding affinity to CYP2C9,Ki,=,44.34,nM,CCCc1oc2ccccc2c(=O)c1C(=O)c1cc(I)c(OC)c(I)c1,CHEMBL1157143,Modeling and synthesis of novel tight-binding inhibitors of cytochrome P450 2C9.,Bioorg. Med. Chem.,2008,16,7,4064,4074,10.1016/j.bmc.2008.01.021,18255300,
2192916,CHEMBL459249,3-(4-methoxybenzoyl)-2-propyl-4H-chromen-4-one,CHEMBL972103,A,,,Cytochrome P450 2C9,Binding affinity to CYP2C9,Ki,=,3120.0,nM,CCCc1oc2ccccc2c(=O)c1C(=O)c1ccc(OC)cc1,CHEMBL1157143,Modeling and synthesis of novel tight-binding inhibitors of cytochrome P450 2C9.,Bioorg. Med. Chem.,2008,16,7,4064,4074,10.1016/j.bmc.2008.01.021,18255300,
2192917,CHEMBL465908,2-ethyl-3-(4-methoxybenzoyl)-4Hchromen-4-one,CHEMBL972103,A,,,Cytochrome P450 2C9,Binding affinity to CYP2C9,Ki,=,6480.0,nM,CCc1oc2ccccc2c(=O)c1C(=O)c1ccc(OC)cc1,CHEMBL1157143,Modeling and synthesis of novel tight-binding inhibitors of cytochrome P450 2C9.,Bioorg. Med. Chem.,2008,16,7,4064,4074,10.1016/j.bmc.2008.01.021,18255300,
2192918,CHEMBL464669,2-ethyl-3-isonicotinoyl-4H-chromen-4-one,CHEMBL972103,A,,,Cytochrome P450 2C9,Binding affinity to CYP2C9,Ki,=,4870.0,nM,CCc1oc2ccccc2c(=O)c1C(=O)c1ccncc1,CHEMBL1157143,Modeling and synthesis of novel tight-binding inhibitors of cytochrome P450 2C9.,Bioorg. Med. Chem.,2008,16,7,4064,4074,10.1016/j.bmc.2008.01.021,18255300,
2594422,CHEMBL457021,Piperidin-1-yl(2-(pyridin-3-yl)quinolin-4-yl)methanone,CHEMBL1012774,A,,,Cytochrome P450 2C9,Inhibition of reconstituted CYP2C9,Ki,=,9740.0,nM,O=C(c1cc(-c2cccnc2)nc2ccccc12)N1CCCCC1,CHEMBL1151734,Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.,J. Med. Chem.,2008,51,24,8000,8011,10.1021/jm8011257,19053752,
2594423,CHEMBL511852,Piperidin-1-yl(2-(pyridin-2-yl)quinolin-4-yl)methanone,CHEMBL1012774,A,,,Cytochrome P450 2C9,Inhibition of reconstituted CYP2C9,Ki,=,23610.0,nM,O=C(c1cc(-c2ccccn2)nc2ccccc12)N1CCCCC1,CHEMBL1151734,Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.,J. Med. Chem.,2008,51,24,8000,8011,10.1021/jm8011257,19053752,
2594424,CHEMBL457857,(2-(Pyridin-4-yl)quinolin-4-yl)(4-(pyrrolidin-1-yl)piperidin-1-yl)methanone,CHEMBL1012774,A,,,Cytochrome P450 2C9,Inhibition of reconstituted CYP2C9,Ki,=,3670.0,nM,O=C(c1cc(-c2ccncc2)nc2ccccc12)N1CCC(N2CCCC2)CC1,CHEMBL1151734,Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.,J. Med. Chem.,2008,51,24,8000,8011,10.1021/jm8011257,19053752,
2594425,CHEMBL515522,(2-(Pyridin-3-yl)quinolin-4-yl)(4-(pyrrolidin-1-yl)piperidin-1-yl)methanone,CHEMBL1012774,A,,,Cytochrome P450 2C9,Inhibition of reconstituted CYP2C9,Ki,=,24080.0,nM,O=C(c1cc(-c2cccnc2)nc2ccccc12)N1CCC(N2CCCC2)CC1,CHEMBL1151734,Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.,J. Med. Chem.,2008,51,24,8000,8011,10.1021/jm8011257,19053752,
2594426,CHEMBL509970,(2-(Pyridin-2-yl)quinolin-4-yl)(4-(pyrrolidin-1-yl)piperidin-1-yl)methanone,CHEMBL1012774,A,,,Cytochrome P450 2C9,Inhibition of reconstituted CYP2C9,Ki,=,76190.0,nM,O=C(c1cc(-c2ccccn2)nc2ccccc12)N1CCC(N2CCCC2)CC1,CHEMBL1151734,Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.,J. Med. Chem.,2008,51,24,8000,8011,10.1021/jm8011257,19053752,
2594427,CHEMBL456181,N-(Naphthalen-2-yl)-2-(pyridin-4-yl)quinoline-4-carboxamide,CHEMBL1012774,A,,,Cytochrome P450 2C9,Inhibition of reconstituted CYP2C9,Ki,=,33.0,nM,O=C(Nc1ccc2ccccc2c1)c1cc(-c2ccncc2)nc2ccccc12,CHEMBL1151734,Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.,J. Med. Chem.,2008,51,24,8000,8011,10.1021/jm8011257,19053752,
2594428,CHEMBL456182,N-(Naphthalen-2-yl)-2-(pyridin-3-yl)quinoline-4-carboxamide,CHEMBL1012774,A,,,Cytochrome P450 2C9,Inhibition of reconstituted CYP2C9,Ki,=,1150.0,nM,O=C(Nc1ccc2ccccc2c1)c1cc(-c2cccnc2)nc2ccccc12,CHEMBL1151734,Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.,J. Med. Chem.,2008,51,24,8000,8011,10.1021/jm8011257,19053752,
2594429,CHEMBL456998,N-(Naphthalen-2-yl)-2-(pyridin-2-yl)quinoline-4-carboxamide,CHEMBL1012774,A,,,Cytochrome P450 2C9,Inhibition of reconstituted CYP2C9,Ki,=,10670.0,nM,O=C(Nc1ccc2ccccc2c1)c1cc(-c2ccccn2)nc2ccccc12,CHEMBL1151734,Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.,J. Med. Chem.,2008,51,24,8000,8011,10.1021/jm8011257,19053752,
2594430,CHEMBL514730,N-(Naphthalen-1-ylmethyl)-2-(pyridin-4-yl)quinoline-4-carboxamide,CHEMBL1012774,A,,,Cytochrome P450 2C9,Inhibition of reconstituted CYP2C9,Ki,=,125.0,nM,O=C(NCc1cccc2ccccc12)c1cc(-c2ccncc2)nc2ccccc12,CHEMBL1151734,Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.,J. Med. Chem.,2008,51,24,8000,8011,10.1021/jm8011257,19053752,
2594431,CHEMBL463577,N-(Naphthalen-1-ylmethyl)-2-(pyridin-3-yl)quinoline-4-carboxamide,CHEMBL1012774,A,,,Cytochrome P450 2C9,Inhibition of reconstituted CYP2C9,Ki,=,152.0,nM,O=C(NCc1cccc2ccccc12)c1cc(-c2cccnc2)nc2ccccc12,CHEMBL1151734,Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.,J. Med. Chem.,2008,51,24,8000,8011,10.1021/jm8011257,19053752,
2594432,CHEMBL463774,N-(Naphthalen-1-ylmethyl)-2-(pyridin-2-yl)quinoline-4-carboxamide,CHEMBL1012774,A,,,Cytochrome P450 2C9,Inhibition of reconstituted CYP2C9,Ki,>,43500.0,nM,O=C(NCc1cccc2ccccc12)c1cc(-c2ccccn2)nc2ccccc12,CHEMBL1151734,Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.,J. Med. Chem.,2008,51,24,8000,8011,10.1021/jm8011257,19053752,
2594433,CHEMBL463976,N-Phenyl-2-(pyridin-4-yl)quinoline-4-carboxamide,CHEMBL1012774,A,,,Cytochrome P450 2C9,Inhibition of reconstituted CYP2C9,Ki,=,100.0,nM,O=C(Nc1ccccc1)c1cc(-c2ccncc2)nc2ccccc12,CHEMBL1151734,Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.,J. Med. Chem.,2008,51,24,8000,8011,10.1021/jm8011257,19053752,
2594434,CHEMBL464389,N-Phenyl-2-(pyridin-3-yl)quinoline-4-carboxamide,CHEMBL1012774,A,,,Cytochrome P450 2C9,Inhibition of reconstituted CYP2C9,Ki,=,4060.0,nM,O=C(Nc1ccccc1)c1cc(-c2cccnc2)nc2ccccc12,CHEMBL1151734,Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.,J. Med. Chem.,2008,51,24,8000,8011,10.1021/jm8011257,19053752,
2594435,CHEMBL513115,N-Phenyl-2-(pyridin-2-yl)quinoline-4-carboxamide,CHEMBL1012774,A,,,Cytochrome P450 2C9,Inhibition of reconstituted CYP2C9,Ki,=,3470.0,nM,O=C(Nc1ccccc1)c1cc(-c2ccccn2)nc2ccccc12,CHEMBL1151734,Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.,J. Med. Chem.,2008,51,24,8000,8011,10.1021/jm8011257,19053752,
2594436,CHEMBL464595,"6,8-Dimethyl-N-(naphthalen-2-yl)-2-(pyridin-4-yl)quinoline-4-carboxamide",CHEMBL1012774,A,,,Cytochrome P450 2C9,Inhibition of reconstituted CYP2C9,Ki,=,11.0,nM,Cc1cc(C)c2nc(-c3ccncc3)cc(C(=O)Nc3ccc4ccccc4c3)c2c1,CHEMBL1151734,Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.,J. Med. Chem.,2008,51,24,8000,8011,10.1021/jm8011257,19053752,
2594437,CHEMBL516696,"6,8-Dimethyl-N-(naphthalen-2-yl)-2-(pyridin-3-yl)quinoline-4-carboxamide",CHEMBL1012774,A,,,Cytochrome P450 2C9,Inhibition of reconstituted CYP2C9,Ki,=,8550.0,nM,Cc1cc(C)c2nc(-c3cccnc3)cc(C(=O)Nc3ccc4ccccc4c3)c2c1,CHEMBL1151734,Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.,J. Med. Chem.,2008,51,24,8000,8011,10.1021/jm8011257,19053752,
2594438,CHEMBL514090,"6,8-Dimethyl-N-(naphthalen-2-yl)-2-(pyridin-2-yl)quinoline-4-carboxamide",CHEMBL1012774,A,,,Cytochrome P450 2C9,Inhibition of reconstituted CYP2C9,Ki,>,20600.0,nM,Cc1cc(C)c2nc(-c3ccccn3)cc(C(=O)Nc3ccc4ccccc4c3)c2c1,CHEMBL1151734,Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.,J. Med. Chem.,2008,51,24,8000,8011,10.1021/jm8011257,19053752,
2594439,CHEMBL455976,6-Chloro-N-(naphthalen-2-yl)-2-(pyridin-4-yl)quinoline-4-carboxamide,CHEMBL1012774,A,,,Cytochrome P450 2C9,Inhibition of reconstituted CYP2C9,Ki,=,12.0,nM,O=C(Nc1ccc2ccccc2c1)c1cc(-c2ccncc2)nc2ccc(Cl)cc12,CHEMBL1151734,Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.,J. Med. Chem.,2008,51,24,8000,8011,10.1021/jm8011257,19053752,
2594440,CHEMBL455974,6-Chloro-N-(naphthalen-2-yl)-2-(pyridin-3-yl)quinoline-4-carboxamide,CHEMBL1012774,A,,,Cytochrome P450 2C9,Inhibition of reconstituted CYP2C9,Ki,=,1890.0,nM,O=C(Nc1ccc2ccccc2c1)c1cc(-c2cccnc2)nc2ccc(Cl)cc12,CHEMBL1151734,Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.,J. Med. Chem.,2008,51,24,8000,8011,10.1021/jm8011257,19053752,
2594441,CHEMBL455975,6-Bromo-N-(naphthalen-2-yl)-2-(pyridin-4-yl)quinoline-4-carboxamide,CHEMBL1012774,A,,,Cytochrome P450 2C9,Inhibition of reconstituted CYP2C9,Ki,=,9.0,nM,O=C(Nc1ccc2ccccc2c1)c1cc(-c2ccncc2)nc2ccc(Br)cc12,CHEMBL1151734,Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.,J. Med. Chem.,2008,51,24,8000,8011,10.1021/jm8011257,19053752,
2594442,CHEMBL456184,6-Bromo-N-(naphthalen-2-yl)-2-(pyridin-3-yl)quinoline-4-carboxamide,CHEMBL1012774,A,,,Cytochrome P450 2C9,Inhibition of reconstituted CYP2C9,Ki,>,37850.0,nM,O=C(Nc1ccc2ccccc2c1)c1cc(-c2cccnc2)nc2ccc(Br)cc12,CHEMBL1151734,Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.,J. Med. Chem.,2008,51,24,8000,8011,10.1021/jm8011257,19053752,
2594443,CHEMBL456185,N-(Naphthalen-1-yl)-2-(pyridin-3-yl)quinoline-4-carboxamide,CHEMBL1012774,A,,,Cytochrome P450 2C9,Inhibition of reconstituted CYP2C9,Ki,=,1250.0,nM,O=C(Nc1cccc2ccccc12)c1cc(-c2cccnc2)nc2ccccc12,CHEMBL1151734,Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.,J. Med. Chem.,2008,51,24,8000,8011,10.1021/jm8011257,19053752,
2594444,CHEMBL515841,N-(Naphthalen-1-yl)-2-(pyridin-2-yl)quinoline-4-carboxamide,CHEMBL1012774,A,,,Cytochrome P450 2C9,Inhibition of reconstituted CYP2C9,Ki,=,1320.0,nM,O=C(Nc1cccc2ccccc12)c1cc(-c2ccccn2)nc2ccccc12,CHEMBL1151734,Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.,J. Med. Chem.,2008,51,24,8000,8011,10.1021/jm8011257,19053752,
2594445,CHEMBL511703,Piperidin-1-yl(2-(pyridin-4-yl)quinolin-4-yl)methanone,CHEMBL1012774,A,,,Cytochrome P450 2C9,Inhibition of reconstituted CYP2C9,Ki,=,9940.0,nM,O=C(c1cc(-c2ccncc2)nc2ccccc12)N1CCCCC1,CHEMBL1151734,Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.,J. Med. Chem.,2008,51,24,8000,8011,10.1021/jm8011257,19053752,
2594451,CHEMBL514730,N-(Naphthalen-1-ylmethyl)-2-(pyridin-4-yl)quinoline-4-carboxamide,CHEMBL1012777,A,,,Cytochrome P450 2C9,Inhibition of purified CYP2C9,Ki,=,113.0,nM,O=C(NCc1cccc2ccccc12)c1cc(-c2ccncc2)nc2ccccc12,CHEMBL1151734,Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.,J. Med. Chem.,2008,51,24,8000,8011,10.1021/jm8011257,19053752,
5089031,CHEMBL638,"(2R,3S)-2-(2,4-Difluoro-phenyl)-3-(5-fluoro-pyrimidin-4-yl)-1-[1,2,4]triazol-1-yl-butan-2-ol",CHEMBL1634994,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of CYP2C9 in human liver microsomes assessed as Tolbutamide 4-methylhydroxylation after 60 mins by Dixon plot analysis,Ki,=,2800.0,nM,C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F,CHEMBL1629616,"Comprehensive in vitro analysis of voriconazole inhibition of eight cytochrome P450 (CYP) enzymes: major effect on CYPs 2B6, 2C9, 2C19, and 3A.",Antimicrob. Agents Chemother.,2009,53,2,541,551,10.1128/aac.01123-08,19029318,
6075058,CHEMBL956,2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid,CHEMBL1743395,A,,Homo sapiens,Cytochrome P450 2C9,Mechanism based inhibition of human cytochrome P450 2C9,Ki,=,3700.0,nM,CC(C(=O)O)c1ccc(C(=O)c2cccs2)cc1,CHEMBL1743341,Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.,Curr. Drug Metab.,2005,6,1,413,454,10.2174/138920005774330639,16248836,
6075060,CHEMBL267744,"[2,3-Dichloro-4-(thiophene-2-carbonyl)-phenoxy]-acetic acid (ticrynafen)",CHEMBL1743396,A,,Homo sapiens,Cytochrome P450 2C9,Mechanism based inhibition of human cytochrome P450 2C9,Ki,=,4300.0,nM,O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl,CHEMBL1743341,Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.,Curr. Drug Metab.,2005,6,1,413,454,10.2174/138920005774330639,16248836,
6075064,CHEMBL9509,"(2R,3R)-3,5,7-Trihydroxy-2-[3-(4-hydroxy-3-methoxy-phenyl)-2-hydroxymethyl-2,3-dihydro-benzo[1,4]dioxin-6-yl]-chroman-4-one",CHEMBL1743408,A,,Homo sapiens,Cytochrome P450 2C9,Mechanism based inhibition of human cytochrome P450 2C9 measured by 7-EFC O-deethylation,Ki,=,5000.0,nM,COc1cc(C2Oc3cc([C@H]4Oc5cc(O)cc(O)c5C(=O)[C@@H]4O)ccc3OC2CO)ccc1O,CHEMBL1743341,Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.,Curr. Drug Metab.,2005,6,1,413,454,10.2174/138920005774330639,16248836,
6191761,CHEMBL1775179,"isopropyl 4-(1-(2-fluoro-4-(methylsulfonyl)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yloxy)piperidine-1-carboxylate",CHEMBL1775801,A,,,Cytochrome P450 2C9,Inhibition of CYP2C9,Ki,=,100.0,nM,CC(C)OC(=O)N1CCC(Oc2ncnc3c2cnn3-c2ccc(S(C)(=O)=O)cc2F)CC1,CHEMBL1773020,Discovery of fused bicyclic agonists of the orphan G-protein coupled receptor GPR119 with in vivo activity in rodent models of glucose control.,Bioorg. Med. Chem. Lett.,2011,21,10,3134,3141,10.1016/j.bmcl.2011.03.007,21444206,
15451144,CHEMBL43469,"5-[(1R,3aR,4S,6aR)-4-(1,3-benzodioxol-5-yl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-1,3-benzodioxole",CHEMBL3540468,A,AH22,Homo sapiens,Cytochrome P450 2C9,Mechanism-based inhibition of recombinant human CYP2C9 expressed in microsomes isolated from Saccharomyces cerevisiae AH22 cells assessed as diclofenac 4'-hydroxylation preincubated for 5 to 10 mins followed by substrate addition measured after 15 mins by HPLC analysis,Ki,=,6800.0,nM,c1cc2c(cc1[C@H]1OC[C@@H]3[C@H](c4ccc5c(c4)OCO5)OC[C@H]13)OCO2,CHEMBL3525932,Comparison of metabolism of sesamin and episesamin by drug-metabolizing enzymes in human liver.,Drug Metab. Dispos.,2012,40,10,1917,1926,10.1124/dmd.112.045906,22752007,
15461257,CHEMBL1951575,2-(4-(4-(tert-butylcarbamoyl)-2-(4-cyclopropylphenylsulfonamido)phenoxy)-5-chloro-2-fluorophenyl)acetic acid,CHEMBL3531866,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of CYP2C9 in human liver microsomes using diclofenac as substrate after 5 to 30 mins by LC-MS/MS analysis,Ki,>,30000.0,nM,CC(C)(C)NC(=O)c1ccc(Oc2cc(F)c(CC(=O)O)cc2Cl)c(NS(=O)(=O)c2ccc(C3CC3)cc2Cl)c1,CHEMBL3526017,"Predicting the drug interaction potential of AMG 853, a dual antagonist of the D-prostanoid and chemoattractant receptor-homologous molecule expressed on T helper 2 cells receptors.",Drug Metab. Dispos.,2012,40,12,2239,2249,10.1124/dmd.112.047928,22930276,
15461259,CHEMBL3526979,"(2S,3S,4S,5R,6S)-6-(2-(4-(4-(tert-butylcarbamoyl)-2-(2-chloro-4-cyclopropylphenylsulfonamido)phenoxy)-5-chloro-2-fluorophenyl)acetoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid",CHEMBL3531866,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of CYP2C9 in human liver microsomes using diclofenac as substrate after 5 to 30 mins by LC-MS/MS analysis,Ki,>,30000.0,nM,CC(C)(C)NC(=O)c1ccc(Oc2cc(F)c(CC(=O)O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)cc2Cl)c(NS(=O)(=O)c2ccc(C3CC3)cc2Cl)c1,CHEMBL3526017,"Predicting the drug interaction potential of AMG 853, a dual antagonist of the D-prostanoid and chemoattractant receptor-homologous molecule expressed on T helper 2 cells receptors.",Drug Metab. Dispos.,2012,40,12,2239,2249,10.1124/dmd.112.047928,22930276,
15464465,CHEMBL484853,"2-((4aR,10aS)-5,6-dihydroxy-7-isopropyl-1,1-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthren-4a-yl)acetic acid",CHEMBL3541529,A,Hepatocyte,Homo sapiens,Cytochrome P450 2C9,Inhibition of CYP2C9 activity in human hepatocytes after 30 mins by liquid chromatography/tandem mass spectroscopy,Ki,=,9200.0,nM,CC(C)c1cc2c(c(O)c1O)[C@@]1(C(=O)O)CCCC(C)(C)[C@@H]1CC2,CHEMBL3526111,"In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties.",Drug Metab. Dispos.,2012,40,7,1263,1267,10.1124/dmd.112.044909,22531045,
15469075,CHEMBL1200681,SID56320471,CHEMBL3536201,A,,Homo sapiens,Cytochrome P450 2C9,Inhibition of recombinant human CYP2C9 expressed in microsomes isolated from baculovirus infected insect cell after 10 mins,Ki,=,7400.0,nM,CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)[O-])CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1.[Na+],CHEMBL3525951,Reevaluation of the microsomal metabolism of montelukast: major contribution by CYP2C8 at clinically relevant concentrations.,Drug Metab. Dispos.,2011,39,5,904,911,10.1124/dmd.110.037689,21289076,
22482109,CHEMBL190461,"2-(6-Isopropenyl-3-methyl-cyclohex-2-enyl)-5-pentyl-benzene-1,3-diol (Cannabidiol)",CHEMBL4687730,A,,Homo sapiens,Cytochrome P450 2C9,Competitive inhibition of CYP2C9 in pooled human liver microsomes using S-warfarin as substrate preincubated for 5 mins followed by NADPH-generating system addition and measured after 20 mins by Lineweaver-Burk plot analysis,Ki,=,5600.0,nM,C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCCCC)cc1O,CHEMBL4680278,The Essential Medicinal Chemistry of Cannabidiol (CBD).,J Med Chem,2020,63,21,12137,12155,10.1021/acs.jmedchem.0c00724,32804502,
